92% Survival Rate: Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma

Immune signatures may predict adverse events from immunotherapy

Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma - EurekAlert